Isaure Vanmeerbeek

4PUBLICATIONS
53CO-AUTHORS
Tumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 19, 2024
Targeting conserved TIM3+VISTA+ tumor-associated macrophages overcomes resistance to cancer immunotherapy.

Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten

|Apr 12, 2023
Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer.

Stefan Naulaerts, Angeliki Datsi, Daniel M Borras

|Aug 18, 2022
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages.

Aleksandar Murgaski, Máté Kiss, Helena Van Damme

|Nov 19, 2021
Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer.

Jenny Sprooten, Ann Vankerckhoven, Isaure Vanmeerbeek

Pageof 1